The present invention relates to compounds of formula I which are prodrugs of caspase inhibitors and pharmaceutically acceptable salts thereof. This invention further relates to the release of caspase inhibitors from these compounds through selective bond cleavage. This invention further relates to pharmaceutical compositions comprising these compounds, which are particularly well-suited for treatment of caspase-mediated diseases, including inflammatory and degenerative diseases. This invention further relates to methods for preparing compounds of this invention.
US7410956B2
申请人:——
公开号:US7410956B2
公开(公告)日:2008-08-12
US9956260B1
申请人:——
公开号:US9956260B1
公开(公告)日:2018-05-01
[EN] PHOSPHOLIPIDS AS CASPASE INHIBITOR PRODRUGS<br/>[FR] PHOSPHOLIPIDES TELS QUE DES PROMEDICAMENTS INHIBITEURS DE CASPASES
申请人:VERTEX PHARMA
公开号:WO2003068242A1
公开(公告)日:2003-08-21
The present invention relates to compounds of formula (I): which are prodrugs of caspase inhibitors and pharmaceutically acceptable salts thereof. This invention further relates to the release of caspase inhibitors from these compounds through selective bond cleavage. This invention further relates to pharmaceutical compositions comprising these compounds, which are particularly well-suited for treatment of caspase-mediated diseases, including inflammatory and degenerative diseases. This invention further relates to methods for preparing compounds of this invention.